Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Recurrence
×
Asparaginase
×
Clear all
Filters
3
NCT01518517
2022-02-02
GRASPIVOTALL
ERYtech Pharma
Phase 2/3
Completed
85 enrolled
13 charts